
Frank Sinicrope, MD
@fasinicropemd
Professor Med Onc + GI, researcher @MayoClinic. Interests: #colorectalcancer, #GIcancer, #Immunotherapy. #hereditarycancers. Views my own.@FASinicropeMD
ID: 1201998583383416833
https://www.mayo.edu/research/faculty/sinicrope-frank-a-m-d/bio-00028129 03-12-2019 22:56:23
819 Tweet
1,1K Followers
585 Following








For dMMR colon cancer, FOLFOX + atezolizumab per ATOMIC is now incorporated into the NCCN Guidelines. Mayo Clinic Comprehensive Cancer Center Alliance for Clinical Trials in Oncology The ASCO Post Colorectal Cancer Alliance Cure GI Cancers Fight Colorectal Cancer


Hot off the press and pleased to collaborate on this important study. Patterns in genomic mutations among patients with early-onset colorect... sciencedirect.com/science/articl… Mayo Clinic Comprehensive Cancer Center Cure GI Cancers Colorectal Cancer Alliance Fight Colorectal Cancer Mayo Clinic Gastroenterology & Hepatology




Enjoyed providing an update on blood-based cancer screening tests including for CRC at ESMO GI. Mayo Clinic Comprehensive Cancer Center Mayo Clinic Gastroenterology & Hepatology ASCO AACR American Gastroenterological Association (AGA)

Implications of BRAF V600E in dMMR/MSI-H pts treated with ICIs. Prognostic impact of the BRAF V600E mutation in patients with MSI-high... sciencedirect.com/science/articl… AACR Journal of Clinical Oncology ASCO Mayo Clinic Comprehensive Cancer Center




Check out our new publication on the use of a CDK2/9 inhibitor for treatment of BRAF mutant colorectal cancer. rdcu.be/ezzYF Mayo Clinic Comprehensive Cancer Center Mayo Clinic AACR @asco Fight Colorectal Cancer Colorectal Cancer Alliance American Gastroenterological Association (AGA) Mayo Clinic Gastroenterology & Hepatology

🔥off the press, now fully published Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Annals of Oncology doi.org/10.1016/j.anno… 😅all you need to know! ESMO - Eur. Oncology

